NCT02572271

Brief Summary

The purpose of this study is to compare two different techniques of mastopexy with autologous augmentation, the Lower Pole Subglandular Advancement Mastoplasty (LOPOSAM) and Rubins Mastopexy with autologous augmentation, in massive weight loss patients to see if one technique is superior to the other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 3, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 8, 2015

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2017

Completed
Last Updated

August 22, 2018

Status Verified

August 1, 2018

Enrollment Period

2.2 years

First QC Date

October 3, 2015

Last Update Submit

August 20, 2018

Conditions

Keywords

Autologous augmentationMastopexyMassive weight loss

Outcome Measures

Primary Outcomes (1)

  • Operation Time

    The time of surgery from start to finish is registered for both techniques.

    Intraoperative

Secondary Outcomes (4)

  • Costs of treatment

    1 year

  • Breast measurements

    1 year

  • Cosmetic result

    1 year

  • Complications

    3 months

Study Arms (2)

Rubins Mastopexy

ACTIVE COMPARATOR

Patients are allocated to a mastopexy using Rubins technique

Procedure: Rubins Mastopexy

LOPOSAM

ACTIVE COMPARATOR

Patients are allocated to a mastopexy using the LOPOSAM technique

Procedure: LOPOSAM

Interventions

The surgical technique described by Rubin is performed. No other intervention.

Rubins Mastopexy
LOPOSAMPROCEDURE

The surgical technique LOPOSAM is performed. No other intervention.

LOPOSAM

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women that meet the Danish National Board of Health criteria for post bariatric surgery, and is found to be a suitable candidate for autologous augmentation

You may not qualify if:

  • Severe dementia, making informed consent impossible
  • Non-Danish speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital, Department of Plastic and Reconstructive Surgery

Odense C, 5000, Denmark

Location

Related Publications (10)

  • Rubin JP. Mastopexy after massive weight loss: dermal suspension and total parenchymal reshaping. Aesthet Surg J. 2006 Mar-Apr;26(2):214-22. doi: 10.1016/j.asj.2006.01.010.

    PMID: 19338902BACKGROUND
  • Rubin JP, Khachi G. Mastopexy after massive weight loss: dermal suspension and selective auto-augmentation. Clin Plast Surg. 2008 Jan;35(1):123-9. doi: 10.1016/j.cps.2007.08.008.

    PMID: 18061806BACKGROUND
  • Gusenoff JA, Rubin JP. Plastic surgery after weight loss: current concepts in massive weight loss surgery. Aesthet Surg J. 2008 Jul-Aug;28(4):452-5. doi: 10.1016/j.asj.2008.06.001.

    PMID: 19083561BACKGROUND
  • Rubin JP, Gusenoff JA, Coon D. Dermal suspension and parenchymal reshaping mastopexy after massive weight loss: statistical analysis with concomitant procedures from a prospective registry. Plast Reconstr Surg. 2009 Mar;123(3):782-789. doi: 10.1097/PRS.0b013e31819ba1a8.

    PMID: 19319040BACKGROUND
  • Thoma A, Kaur MN, Tsoi B, Ziolkowski N, Duku E, Goldsmith CH. Cost-effectiveness analysis parallel to a randomized controlled trial comparing vertical scar reduction and inverted T-shaped reduction mammaplasty. Plast Reconstr Surg. 2014 Dec;134(6):1093-1107. doi: 10.1097/PRS.0000000000000751.

    PMID: 25255113BACKGROUND
  • Hansson E, Manjer J, Ringberg A. Inter-observer reliability of clinical measurement of suprasternal notch-nipple distance and breast ptosis. Indian J Plast Surg. 2014 Jan;47(1):61-4. doi: 10.4103/0970-0358.129625.

    PMID: 24987206BACKGROUND
  • Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-353. doi: 10.1097/PRS.0b013e3181aee807.

    PMID: 19644246BACKGROUND
  • Fischer JP, Cleveland EC, Shang EK, Nelson JA, Serletti JM. Complications following reduction mammaplasty: a review of 3538 cases from the 2005-2010 NSQIP data sets. Aesthet Surg J. 2014 Jan 1;34(1):66-73. doi: 10.1177/1090820X13515676. Epub 2013 Dec 13.

    PMID: 24334499BACKGROUND
  • Cardoso MJ, Cardoso JS, Wild T, Krois W, Fitzal F. Comparing two objective methods for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat. 2009 Jul;116(1):149-52. doi: 10.1007/s10549-008-0173-4. Epub 2008 Sep 7.

    PMID: 18777134BACKGROUND
  • Godwin Y, Barron EJ, Edmunds MC, Meyer M, Bardsley A, Logan AM, O'Neill TJ, Wood SH. A comparison of the patient and surgeon opinion on the long-term aesthetic outcome of reduction mammaplasty: have we improved over 15 years? J Plast Reconstr Aesthet Surg. 2014 Jul;67(7):932-8. doi: 10.1016/j.bjps.2014.04.006. Epub 2014 May 9.

    PMID: 24860932BACKGROUND

Related Links

MeSH Terms

Conditions

Weight Loss

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Peder Ikander, MD

    Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 3, 2015

First Posted

October 8, 2015

Study Start

September 1, 2015

Primary Completion

November 16, 2017

Study Completion

November 16, 2017

Last Updated

August 22, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations